The global prevalence of erectile dysfunction: a review
- PMID: 31267639
- DOI: 10.1111/bju.14813
The global prevalence of erectile dysfunction: a review
Abstract
Objective: To evaluate the global prevalence of erectile dysfunction (ED); as well as its association with physiological and pathological ageing by examining the relationship between ED and cardiovascular disease (CVD), benign prostatic hyperplasia (BPH), and dementia. We also aimed to characterise discrepancies caused by the use of different ED screening tools.
Methods: The Excerpta Medica dataBASE (EMBASE) and Medical Literature Analysis and Retrieval System Online (MEDLINE) were searched to find population-based studies investigating the prevalence of ED and the association between ED and CVD, BPH, and dementia in the general population.
Results: The global prevalence of ED was 3-76.5%. ED was associated with increasing age. Use of the International Index of Erectile Function (IIEF) and Massachusetts Male Aging Study (MMAS)-derived questionnaire identified a high prevalence of ED in young men. ED was positively associated with CVD. Men with ED have an increased risk of all-cause mortality odds ratio (OR) 1.26 (95% confidence interval [CI] 1.01-1.57), as well as CVD mortality OR 1.43 (95% CI 1.00-2.05). Men with ED are 1.33-6.24-times more likely to have BPH then men without ED, and 1.68-times more likely to develop dementia than men without ED.
Conclusion: ED screening tools in population-based studies are a major source of discrepancy. Non-validated questionnaires may be less sensitive than the IIEF and MMAS-derived questionnaire. ED constitutes a large burden on society given its high prevalence and impact on quality of life, and is also a risk factor for CVD, dementia, and all-cause mortality.
Keywords: #erectiledysfunction; International Index of Erectile Function; Massachusetts Male Aging Study; benign prostatic hyperplasia; cardiovascular disease.
© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.
Similar articles
-
Is erectile dysfunction a reliable indicator of general health status in men?Arab J Urol. 2013 Sep;11(3):203-11. doi: 10.1016/j.aju.2013.07.008. Epub 2013 Sep 14. Arab J Urol. 2013. PMID: 26558083 Free PMC article. Review.
-
Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction-Which Patients Deserve More Attention?J Sex Med. 2020 Aug;17(8):1489-1494. doi: 10.1016/j.jsxm.2020.03.012. Epub 2020 Apr 24. J Sex Med. 2020. PMID: 32340919
-
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.J Sex Med. 2013 Aug;10(8):2044-52. doi: 10.1111/jsm.12212. Epub 2013 Jun 19. J Sex Med. 2013. PMID: 23782459 Clinical Trial.
-
Association between body size and composition and erectile dysfunction in older men: Osteoporotic Fractures in Men Study.J Am Geriatr Soc. 2013 Jan;61(1):46-54. doi: 10.1111/jgs.12073. J Am Geriatr Soc. 2013. PMID: 23311552 Free PMC article.
-
Baseline atrial fibrillation is a risk factor for erectile dysfunction: Systemic review and meta-analysis.Arab J Urol. 2019 Apr 24;17(2):98-105. doi: 10.1080/2090598X.2019.1601001. eCollection 2019. Arab J Urol. 2019. PMID: 31285920 Free PMC article. Review.
Cited by
-
Safety and efficacy of platelet-rich plasma injection for treatment of erectile dysfunction: a prospective randomized controlled study.Basic Clin Androl. 2024 Oct 8;34(1):16. doi: 10.1186/s12610-024-00232-3. Basic Clin Androl. 2024. PMID: 39375600 Free PMC article.
-
Human Papillomavirus Infection and the Risk of Erectile Dysfunction: A Nationwide Population-Based Matched Cohort Study.J Pers Med. 2022 Apr 27;12(5):699. doi: 10.3390/jpm12050699. J Pers Med. 2022. PMID: 35629123 Free PMC article.
-
Colombian Clinical Validation of the International Index of Erectile Function (IIEF-5).Sex Med. 2022 Feb;10(1):100461. doi: 10.1016/j.esxm.2021.100461. Epub 2021 Nov 21. Sex Med. 2022. PMID: 34818605 Free PMC article.
-
Estrogenic endocrine disruptor exposure directly impacts erectile function.Commun Biol. 2024 Apr 2;7(1):403. doi: 10.1038/s42003-024-06048-1. Commun Biol. 2024. PMID: 38565966 Free PMC article.
-
Reflections from practice: innovations in inflatable penile prosthesis pumps benefit both patients and physicians.Transl Androl Urol. 2024 Oct 31;13(10):2351-2353. doi: 10.21037/tau-24-353. Epub 2024 Oct 16. Transl Androl Urol. 2024. PMID: 39507859 Free PMC article. No abstract available.
References
-
- Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50-6
-
- Wessells H, Joyce G, Wise M, Wilt TJ. Erectile dysfunction. J Urol 2007; 177: 1675-81
-
- Fisher WA, Rosen RC, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005; 2: 675-84
-
- Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460-3
-
- Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004; 20: 607-17
LinkOut - more resources
Full Text Sources